Cargando…

Evaluation of selective bone scan staging in prostate cancer – external validation of current strategies and decision-curve analysis

BACKGROUND: Recommendations for staging newly diagnosed prostate cancer patients vary between guidelines and literature. METHODS: Our objective was to validate and compare prediction models selecting newly diagnosed prostate cancer patients for bone scan staging. To achieve this, we validated eleven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiwase, Mrunal D., Jay, Alex, Bulamu, Norma, Teh, Johnathan, Paterson, Felix, Kichenadasse, Ganessan, Vincent, Andrew D., O’Callaghan, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184265/ https://www.ncbi.nlm.nih.gov/pubmed/35288662 http://dx.doi.org/10.1038/s41391-022-00515-8

Ejemplares similares

Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
por: Bulamu, Norma B., et al.
Publicado: (2023)

Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies
por: Li, Jordan Y., et al.
Publicado: (2022)

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer
por: David, Rowan, et al.
Publicado: (2022)

Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review
por: van Dyk, Madelé, et al.
Publicado: (2021)

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19
por: O'Callaghan, M.E., et al.
Publicado: (2020)

Radiation Induced Leiomyosarcoma Three Decades After Treatment for Wilms’ Tumor
por: Khattak, Muhammad A, et al.
Publicado: (2010)

Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report
por: Abbas, M. Nazim, et al.
Publicado: (2021)

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study
por: Mangoni, Arduino A., et al.
Publicado: (2018)

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials
por: Hopkins, Ashley M., et al.
Publicado: (2020)

Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift
por: Hopkins, Ashley M, et al.
Publicado: (2023)

Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab
por: Hopkins, Ashley M, et al.
Publicado: (2020)

Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data
por: Sorich, Michael J, et al.
Publicado: (2016)

A systematic review of instruments for measuring outcomes in economic evaluation within aged care
por: Bulamu, Norma B., et al.
Publicado: (2015)

Economic evaluations in community aged care: a systematic review
por: Bulamu, Norma B., et al.
Publicado: (2018)

ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study
por: Lemech, Charlotte Rose, et al.
Publicado: (2022)

Patient-reported functional outcome measures and treatment choice for prostate cancer
por: Tiruye, Tenaw, et al.
Publicado: (2022)

Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges
por: van Leuven, Jason, et al.
Publicado: (2023)

Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'
por: Rowland, Andrew, et al.
Publicado: (2015)

Usability, Acceptability, and Safety Analysis of a Computer-Tailored Web-Based Exercise Intervention (ExerciseGuide) for Individuals With Metastatic Prostate Cancer: Multi-Methods Laboratory-Based Study
por: Evans, Holly EL, et al.
Publicado: (2021)

Acceptability and Preliminary Efficacy of a Web- and Telephone-Based Personalised Exercise Intervention for Individuals with Metastatic Prostate Cancer: The ExerciseGuide Pilot Randomised Controlled Trial
por: Evans, Holly E. L., et al.
Publicado: (2021)

Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy
por: Booth, Andrew E. C., et al.
Publicado: (2020)

Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial
por: Hopkins, Ashley M., et al.
Publicado: (2021)

Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2021)

Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176”
por: Hopkins, Ashley M., et al.
Publicado: (2021)

Targeted pharmacotherapy after somatic cancer mutation screening
por: Polasek, Thomas M., et al.
Publicado: (2016)

Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting
por: Kaambwa, Billingsley, et al.
Publicado: (2021)

Measuring the Wellbeing of Cancer Patients with Generic and Disease-Specific Instruments
por: Chen, Gang, et al.
Publicado: (2023)

Evaluating a web- and telephone-based personalised exercise intervention for individuals living with metastatic prostate cancer (ExerciseGuide): protocol for a pilot randomised controlled trial
por: Evans, Holly E. L., et al.
Publicado: (2021)

Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease
por: Morris, Lee‐Anne, et al.
Publicado: (2022)

Nuances to precision dosing strategies of targeted cancer medicines
por: Hopkins, Ashley M., et al.
Publicado: (2020)

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
por: Johnston, Ashley W., et al.
Publicado: (2020)

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
por: Hopkins, Ashley M, et al.
Publicado: (2017)

Learning curve of digital intraoral scanning – an in vivo study
por: Róth, Ivett, et al.
Publicado: (2020)

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme
por: Lickliter, Jason D., et al.
Publicado: (2023)

C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2022)

Survival outcomes in men with a positive family history of prostate cancer: a registry based study
por: Ang, Mann, et al.
Publicado: (2020)

Using the weighted area under the net benefit curve for decision curve analysis
por: Talluri, Rajesh, et al.
Publicado: (2016)

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results
por: Coward, Jermaine I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cq5blovn4jl871s4da8jn141rr